Northgate Pet Clinic Clinical Trials
The Clincal Trials Department at Northgate Pet Clinic has participated in over 60 clinical trials since 2010 and currently has five staff members including owner/medical director, Dr. Larry Baker.
We are proud that our efforts in many of those trials have helped numerous medications acquire approval and are currently in use in veterinary clinics across the United States.
Due to our success, our Clinical Trials Department moved into a separate, newly renovated, facility that is solely dedicated to clinical trials. Our 2200 sq. ft. Clinical Trials Facility is designed to support our growth and streamline our efficiency in conducting current and future trials.
Out of the numerous clinical trials that Northgate Pet Clinic has participated in, many medications have been approved by the FDA or USDA and are used in veterinary clinics across the Unites States.
Deramaxx was approved for the control of post-dental surgery pain in dogs
Injectable Onsior was approved for post-operative pain control in dogs
Mirataz was approved for management of weight loss in cats
Bravecto Topical was approved for flea treatment in cats
Nobivac EDGE was approved as a full protection DAPP+L4 vaccine given at half-dose
Galliprant was approved for the control of osteoarthritis pain in dogs
Zenalpha was approved as a sedative and analgesic in dogs
ProHeart12 was approved as an injectable form of heartworm disease prevention for 12 months
Solensia was approved for the control of pain associated with osteoarthritis in cats
Clevor was approved for the induction of vomiting in dogs
Librela was approved for the control of pain associated with osteoarthritis in dogs
MONDAY- FRIDAY .. 8:00 - 5:00
SATURDAY - SUNDAY .. CLOSED